IntrinsicIntrinsic
← All summaries

GLOBE LIFE INC.

GL
Financials & Chart →

Business Summary

Globe Life Inc. is an insurance holding company whose primary subsidiaries are Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American Insurance Company. The company operates in the life and health insurance industry, focusing on individual life and supplemental health limited-benefit insurance products marketed to lower middle-income to middle-income households throughout the United States, with additional operations in Canada and New Zealand. The industry is characterized by regulation at the state level, with agencies having broad administrative powers over premium rates, policy forms, capital adequacy, and trade practices. Key structural forces shaping competition include the ability to operate at lower policy acquisition and administrative expense levels, which allows for competitive rates while maintaining higher underwriting margins.

Globe Life competes with other life and health insurance carriers through policyholder service, price, product design, and sales efforts, and the filing states that no individual company dominates any of Globe Life's life or health insurance markets. The company's health insurance products also compete with health maintenance organizations, preferred provider organizations, and other health care-related institutions. The company's stated competitive advantages include its ability to efficiently reach the lower-middle to middle-income market through exclusive and direct-to-consumer distribution channels, as well as the amount of data and experience it possesses from operating in this same market for over 60 years with essentially the same products.

Globe Life generates revenue primarily through premium income from individual life and supplemental health insurance products, and to a lesser extent through policy charges to policyholder account values on annuity products and certain individual life products. The company's business model is built on multiple distribution channels: a Direct to Consumer Division, exclusive independent agents (American Income Life, Liberty National, and Family Heritage divisions), and independent agents (United American division). The company views its operations by segments: life insurance, supplemental health insurance, and an investment segment that supports the product lines. Profitability for the insurance segments is measured by underwriting margin (premium revenue less policy obligations, policy acquisition costs, and commissions), while the investment segment is measured by excess investment income (net investment income less required interest on policy liabilities).

The life insurance segment is the company's predominant segment, with life premium representing 69% of total premium and life underwriting margin representing 79% of total underwriting margin in 2025. Life insurance products include traditional whole life, term life, and other life insurance, with the company not currently selling interest-sensitive whole life products. Annualized life premium in force was $3,421,143,000 at December 31, 2025, an increase of 4% over $3,299,261,000 a year earlier. The American Income Life Division is the largest contributor of life premium at 53% of total life premium, with net sales of $393,681,000 in 2025. The Direct to Consumer Division had net sales of $112,027,000 and an underwriting margin as a percent of premium of 33% in 2025. The Liberty National Division had premium of $390,094,000 and an underwriting margin as a percent of premium of 44% in 2025.

The health insurance segment primarily includes Medicare Supplement insurance, retiree health insurance, accident coverage, and other limited-benefit supplemental health products such as cancer, critical illness, heart disease, and intensive care products. Health premium accounted for 31% of total premium in 2025, while health underwriting margin accounted for 21% of total underwriting margin. Annualized health premium in force was $1,649,670,000 at December 31, 2025, an increase of 12% from $1,475,846,000 a year earlier. The United American Division is the largest health division in terms of health premium revenue, with net sales up 92% from the prior year to $154,476,000 . The Family Heritage Division had health net sales of $120,311,000 and an underwriting margin as a percent of premium of 37% in 2025. Premium from limited-benefit supplemental health products comprised $851,000,000 of total health premiums, while Medicare Supplement products comprised the remaining $676,000,000 in 2025.

During 2025, the company repurchased 5,420,000 shares of Globe Life Inc. common stock at a total cost of $685,151,000 for an average share price of $126.41 . Additionally, 1,469,000 shares were repurchased for $189,669,000 to offset dilution from stock option exercises, bringing total share repurchases to 6,889,000 shares at a total cost of $874,820,000 . In 2025, the company entered into a 30-year facility agreement with a Delaware Trust in connection with the sale by the trust of $500,000,000 pre-capitalized trust securities redeemable May 15, 2055. The company also received license approval and established an affiliated Bermuda reinsurance company, Globe Life Re Ltd., in the latter part of 2025. Under an intercompany reinsurance agreement initiated in 2025, the company ceded approximately $1,200,000,000 of life statutory reserves from Liberty National Life Insurance Company, Globe Life And Accident Insurance Company, and American Income Life Insurance Company to GL Re as of December 31, 2025.

Net income totaled $1,161,238,000 in 2025, compared with $1,070,762,000 in 2024 and $971,000,000 in 2023. On a diluted per common share basis, net income per common share for 2025 increased 18% to $14.07 , compared to $11.94 in 2024 and $10.07 in 2023. Total premium increased 5% over the same period in the prior year, with life premium increasing 3% from $3,261,347,000 in 2024 to $3,363,470,000 in 2025, and health premium increasing 9% to $1,526,750,000 over the prior-year period of $1,404,925,000 . Total net sales increased 13% from $840,000,000 in 2024 to $948,000,000 in 2025. Book value per share increased 19% from $62.50 to $74.17 , and book value per share excluding accumulated other comprehensive income increased 11% from $86.40 in 2024 to $96.16 in 2025.

Business Outlook

The American Income Life Division continues to focus on growing and strengthening the agency force, specifically through emphasis on agency middle-management growth. The division has made considerable investments in information technology, including a customer relationship management tool for the agency force designed to provide dashboards and drive productivity in lead distribution, conservation of business, and new agent recruiting. The division has also invested in and successfully implemented technology that allows the agency force to engage in virtual recruiting, training, and sales activity, with agents generating the vast majority of sales through virtual presentations. The Liberty National Division continues to execute a long-term plan to grow through expansion from small-town markets in the Southeast to more densely populated areas with larger pools of potential agent recruits and customers, and as this division continues to gain momentum in its sales and recruiting initiatives through advances in technology and utilization of a CRM platform, it anticipates continued growth in recruiting activity, average producing agent count, and net sales.

The Direct to Consumer Division's long-term growth has been fueled by consistent innovation and brand awareness, and the division has implemented new technology to enhance the underwriting process which has improved the conversion of customer inquiries into sales. New initiatives are continuously introduced to help increase response rates, issue rates, and create a seamless customer experience. The juvenile insurance market is an important source of sales as well as a vehicle to reach the parents and grandparents of existing juvenile insureds, and future offerings to parents and grandparents for adult and juvenile insurance are sources of lower acquisition-cost life insurance sales in the future. The United American Division has seen increased demand for Medicare Supplement primarily due to changes in the Medicare Advantage market, and the company adjusts premium rates based upon an annual review of utilization and claim cost trends, submitting rates for approval to insurance department regulators with new premium rates generally becoming effective in the following year on new business issued.

Insurance administrative expenses as a percent of premium were 7.3% for the year ended December 31, 2025, unchanged from 2024. The company evaluates life underwriting margin on a normalized basis that excludes the impacts of annual assumption updates, and on a normalized basis, life underwriting margin for 2025 was $1,400,000,000 or 41% of premium, compared with $1,300,000,000 or 40% of premium in 2024. On a normalized basis, health underwriting margin for 2025 was $387,000,000 or 25% of premium, compared with $383,000,000 or 27% of premium in 2024.

The company had 3,695 full-time, part-time, and temporary employees as of December 31, 2025, a 1% decrease over the prior year. The company engages over 17,000 independently-contracted insurance agents. The average producing agent count across all exclusive agencies increased 3% over the prior year, with American Income at 11,920 average producing agents, Liberty National at 3,846 , and Family Heritage at 1,527 .

The company has an ongoing share repurchase program that began in 1986, and on November 18, 2024, the Board of Directors authorized the repurchase of up to $1,800,000,000 under the company's existing share repurchase program. At December 31, 2025, the company had slightly more than $1,100,000,000 remaining under the authorization to repurchase. Since implementing the share repurchase program in 1986, the company has used $11,000,000,000 to repurchase Globe Life Inc. common shares. The quarterly dividend has continually increased over the past three years, with the quarterly dividend by annual year being $0.3300 for projected 2026, $0.2700 for 2025, $0.2400 for 2024, and $0.2250 for 2023.

The company faces headwinds from the risk that actual or alleged misclassification of independent contractors at its insurance subsidiaries could result in adverse legal, tax, or financial consequences, as a significant portion of sales agents are independent contractors. The company is subject to civil litigation, including class and collective action litigation, alleging improper classification of certain sales agents as independent contractors. In September 2024, the Equal Employment Opportunity Commission notified the company that it had determined that all sales agents affiliated with State General Agent Simon Arias were employees, not independent contractors, of Globe Life Inc. and/or AIL. Future changes in rules, regulations, or interpretations, or significant adverse judgments in litigation, could require reclassification of all or a portion of agents as employees, which could significantly increase operating costs.

The company is subject to liquidity risks associated with sourcing a concentration of its funding from the Federal Home Loan Bank, and if the FHLB were to change its definition of eligible collateral, the company could be required to post additional amounts of collateral. Additionally, if the company's creditworthiness falls below the FHLB's requirements or if legislative or other political actions cause changes to the FHLB's mandate or to the eligibility of life insurance companies to be members of the FHLB system, the company could be required to find other sources to replace this funding. The company has been the target of several short sellers who have published reports making allegations about the company, which resulted in a significant decline in the price of its common stock, negative publicity, reputational damage, and a putative securities class action litigation and derivative shareholder litigation.

Risk Factors

The company's investments are subject to market and credit risks, with the fixed maturity portfolio having a fair value of $17,589,342,000 at December 31, 2025, and a net unrealized loss position of $1,200,000,000 . A significant increase in interest rates could cause a material temporary decline in fair value, and a 100 basis point increase in interest rates would reduce the market value of the fixed maturity portfolio to $15,992,000,000 . The company is exposed to the risk that actual-to-expected rates of mortality, morbidity, and policyholder behavior could materially negatively affect results, with a 1% increase in mortality impacting net income by $(47,167,000) and a 10% increase in lapses impacting net income by $95,695,000 . The company faces liquidity risk as a holding company with no direct operations, with its principal asset being the capital stock of its insurance subsidiaries, and dividend availability from subsidiaries is projected to be $719,000,000 in 2026. The company has been subject to short selling strategies, with reports resulting in a significant decline in the price of its common stock and leading to a putative securities class action and five shareholder derivative lawsuits. The company ceded approximately $1,200,000,000 of life statutory reserves to its Bermuda reinsurance subsidiary GL Re, and future regulatory changes by the Bermuda Monetary Authority could impact capital efficiency and require additional capital contributions.

Management Priorities

Management's message emphasizes that Globe Life serves the lower-middle to middle-income market, which it believes is underserved, has significant growth potential, and provides a distinct competitive advantage protected by the company's ability to efficiently reach this market through both exclusive and direct-to-consumer distribution channels, as well as the amount of data and experience possessed from operating in this same market for over 60 years. Management highlights that net income as a return on equity for the year ended December 31, 2025 was 20.9% and net operating income as an ROE, excluding accumulated other comprehensive income, was 16.0% . Management notes that the company continues to see positive signs in its core operations, including sales and premium growth, and continues to achieve an operating ROE (excluding accumulated other comprehensive income) generally in the mid-teens. The strategic priorities emphasized include growing the agency force, particularly through agency middle-management growth and investments in information technology, and continuing the share repurchase program as a primary use of excess cash flow when market conditions are favorable.

View Source Annual Report on SEC.gov ↗

References

  1. [1] Item 1, Business — Life Insurance
  2. [2] Item 1, Business — Life Insurance
  3. [3] Item 7, MD&A — Life Insurance Net Sales by Distribution Channel
  4. [4] Item 7, MD&A — Life Insurance Net Sales by Distribution Channel
  5. [5] Item 7, MD&A — Life Insurance Underwriting Margin by Distribution Channel
  6. [6] Item 7, MD&A — Life Insurance Premium by Distribution Channel
  7. [7] Item 7, MD&A — Life Insurance Underwriting Margin by Distribution Channel
  8. [8] Item 1, Business — Health Insurance
  9. [9] Item 1, Business — Health Insurance
  10. [10] Item 7, MD&A — Health Insurance Net Sales by Distribution Channel
  11. [11] Item 7, MD&A — Health Insurance Net Sales by Distribution Channel
  12. [12] Item 7, MD&A — Health Insurance Underwriting Margin by Distribution Channel
  13. [13] Item 7, MD&A — Health Insurance
  14. [14] Item 7, MD&A — Health Insurance
  15. [15] Item 7, MD&A — Analysis of Share Purchases
  16. [16] Item 7, MD&A — Analysis of Share Purchases
  17. [17] Item 7, MD&A — Current Highlights
  18. [18] Item 7, MD&A — Analysis of Share Purchases
  19. [19] Item 7, MD&A — Analysis of Share Purchases
  20. [20] Item 7, MD&A — Analysis of Share Purchases
  21. [21] Item 7, MD&A — Analysis of Share Purchases
  22. [22] Item 7, MD&A — Parent Company Liquidity
  23. [23] Item 1A, Risk Factors — Financial and Strategic Risks
  24. [24] Item 7, MD&A — Summary of Operations
  25. [25] Item 7, MD&A — Summary of Operations
  26. [26] Item 7, MD&A — Summary of Operations
  27. [27] Item 7, MD&A — Summary of Operations
  28. [28] Item 7, MD&A — Summary of Operations
  29. [29] Item 7, MD&A — Summary of Operations
  30. [30] Item 7, MD&A — Life Insurance Summary of Results
  31. [31] Item 7, MD&A — Life Insurance Summary of Results
  32. [32] Item 7, MD&A — Health Insurance Summary of Results
  33. [33] Item 7, MD&A — Health Insurance Summary of Results
  34. [34] Item 7, MD&A — Current Highlights
  35. [35] Item 7, MD&A — Current Highlights
  36. [36] Item 7, MD&A — Current Highlights
  37. [37] Item 7, MD&A — Current Highlights
  38. [38] Item 7, MD&A — Current Highlights
  39. [39] Item 7, MD&A — Current Highlights
  40. [40] Item 7, MD&A — Operating Expenses
  41. [41] Item 7, MD&A — Life Insurance
  42. [42] Item 7, MD&A — Life Insurance
  43. [43] Item 7, MD&A — Health Insurance
  44. [44] Item 7, MD&A — Health Insurance
  45. [45] Item 1, Business — Human Capital Management
  46. [46] Item 1, Business — Human Capital Management
  47. [47] Item 7, MD&A — American Income Life Division
  48. [48] Item 7, MD&A — Liberty National Division
  49. [49] Item 7, MD&A — Family Heritage Division
  50. [50] Item 7, MD&A — Share Repurchases
  51. [51] Item 7, MD&A — Share Repurchases
  52. [52] Item 7, MD&A — Share Repurchases
  53. [53] Item 7, MD&A — Shareholder's Equity
  54. [54] Item 7, MD&A — Shareholder's Equity
  55. [55] Item 7, MD&A — Shareholder's Equity
  56. [56] Item 7, MD&A — Shareholder's Equity
  57. [57] Item 8, Consolidated Balance Sheets
  58. [58] Item 7, MD&A — Fixed Maturity Portfolio Selected Information
  59. [59] Item 7, MD&A — Market Risk Sensitivity
  60. [60] Item 7, MD&A — Critical Accounting Estimates
  61. [61] Item 7, MD&A — Critical Accounting Estimates
  62. [62] Item 7, MD&A — Parent Company Liquidity
  63. [63] Item 1A, Risk Factors — Financial and Strategic Risks
  64. [64] Item 7, MD&A — Current Highlights
  65. [65] Item 7, MD&A — Current Highlights
  66. [66] Item 8, Consolidated Statements of Operations
  67. [67] Item 8, Consolidated Statements of Operations
  68. [68] Item 8, Consolidated Statements of Operations
  69. [69] Item 8, Consolidated Statements of Operations
  70. [70] Item 7, MD&A — Summary of Operations
  71. [71] Item 7, MD&A — Summary of Operations
  72. [72] Item 7, MD&A — Analysis of Profitability by Segment
  73. [73] Item 7, MD&A — Analysis of Profitability by Segment
  74. [74] Item 7, MD&A — Summary of Operations
  75. [75] Item 7, MD&A — Summary of Operations
  76. [76] Item 7, MD&A — Analysis of Profitability by Segment
  77. [77] Item 7, MD&A — Analysis of Profitability by Segment
  78. [78] Item 7, MD&A — Analysis of Profitability by Segment
  79. [79] Item 7, MD&A — Analysis of Profitability by Segment
  80. [80] Item 7, MD&A — Analysis of Excess Investment Income
  81. [81] Item 7, MD&A — Analysis of Excess Investment Income
  82. [82] Item 7, MD&A — Summary of Operations
  83. [83] Item 7, MD&A — Summary of Operations
  84. [84] Item 7, MD&A — Shareholder's Equity
  85. [85] Item 7, MD&A — Shareholder's Equity
  86. [86] Item 7, MD&A — Analysis of Share Purchases
  87. [87] Item 7, MD&A — Analysis of Share Purchases
  88. [88] Item 7, MD&A — Consolidated Liquidity

Analysis on 6/11/2026